Literature DB >> 17272746

Plasma fibrinogen, ambulatory blood pressure, and silent cerebrovascular lesions: the Ohasama study.

Yoko Aono1, Takayoshi Ohkubo, Masahiro Kikuya, Azusa Hara, Takeo Kondo, Taku Obara, Hirohito Metoki, Ryusuke Inoue, Kei Asayama, Yoriko Shintani, Junichiro Hashimoto, Kazuhito Totsune, Haruhisa Hoshi, Hiroshi Satoh, Shin-ichi Izumi, Yutaka Imai.   

Abstract

OBJECTIVE: Twenty-four-hour ambulatory blood pressure (24-hour ABP) values are considered a powerful predictor of stroke. Silent cerebrovascular lesions are associated with an increased risk of stroke. Because fibrinogen is a major determinant of plasma viscosity, an elevated fibrinogen level might also be associated with stroke risk. We evaluated the association of 24-hour ABP and plasma fibrinogen levels with the risk of silent cerebrovascular lesions (white matter hyperintensity and lacunar infarct) detected by MRI. METHODS AND
RESULTS: The study cohort comprised 958 individuals from the general population of Ohasama, a rural Japanese community. Multiple logistic regression analysis adjusted for age, sex, smoking and drinking status, use of antihypertensive medication, body mass index, 24-hour ABP, and a history of hypercholesterolemia, diabetes mellitus, and atrial fibrillation demonstrated that each 1-SD increase in fibrinogen level was associated with a significantly increased risk of silent cerebrovascular lesions (odds ratio, 1.26; P=0.001). The 24-hour ABP was also significantly and independently associated with the risk of silent cerebrovascular lesions. Even when 24-hour ABP values were within normal range (<135/80 mm Hg), elevated fibrinogen levels were associated with an increased risk of silent cerebrovascular lesions. Fibrinogen and 24-hour BP had additive effects on silent cerebrovascular lesions.
CONCLUSION: The 24-hour ABP and plasma fibrinogen levels were closely and independently associated with the risk of silent cerebrovascular lesions including white matter hyperintensity and lacunar infarct.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17272746     DOI: 10.1161/01.ATV.0000258947.17570.38

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

1.  Lifestyle Risk Factors and Findings on Brain Magnetic Resonance Imaging of Older Adult American Indians: The Strong Heart Study.

Authors:  Dean Shibata; Astrid Suchy-Dicey; Cara L Carty; Tara Madhyastha; Tauqeer Ali; Lyle Best; Thomas J Grabowski; W T Longstreth; Dedra Buchwald
Journal:  Neuroepidemiology       Date:  2019-06-04       Impact factor: 3.282

Review 2.  Subclinical Cerebrovascular Disease: Epidemiology and Treatment.

Authors:  Adam de Havenon; Chelsea Meyer; J Scott McNally; Matthew Alexander; Lee Chung
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

Review 3.  Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review.

Authors:  Anna Poggesi; Marco Pasi; Francesca Pescini; Leonardo Pantoni; Domenico Inzitari
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

4.  Changes in haemostatic and platelet activation markers in non-dipper hypertensive patients.

Authors:  Athanasia Agorasti; Efthimia Mourvati; Theodoros Trivellas; Vasilios Papadopoulos; Ioanna Bazntiara; Anna Christoforidou; Ploumis Passadakis
Journal:  Int Urol Nephrol       Date:  2011-03-09       Impact factor: 2.370

Review 5.  Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage.

Authors:  Gary F Mitchell
Journal:  J Appl Physiol (1985)       Date:  2008-09-04

6.  Differential risk factors for lacunar stroke depending on the MRI (white and red) subtypes of microangiopathy.

Authors:  Jae-Hyun Park; Sookyung Ryoo; Suk Jae Kim; Gyeong-Moon Kim; Chin-Sang Chung; Kwang Ho Lee; Oh Young Bang
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

7.  Value of Combining of the NLR and the Fibrinogen Level for Predicting Stroke-Associated Pneumonia.

Authors:  Wei Cheng; Lichang Chen; Huapeng Yu; Dongzhu Lu; Rong Yu; Jian Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-28       Impact factor: 2.570

8.  Fibrinogen is an Independent Risk Factor for White Matter Hyperintensities in CADASIL but not in Sporadic Cerebral Small Vessel Disease Patients.

Authors:  Xingfang Guo; Bin Deng; Lizi Zhong; Fen Xie; Qing Qiu; Xiaobo Wei; Wenya Wang; Jiangping Xu; Ganqiang Liu; Wong Peter Tsun Hon; Midori A Yenari; Shuzhen Zhu; Qing Wang
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

9.  The silent and apparent neurological injury in transcatheter aortic valve implantation study (SANITY): concept, design and rationale.

Authors:  Jonathon P Fanning; Allan J Wesley; David G Platts; Darren L Walters; Eamonn M Eeles; Michael Seco; Oystein Tronstad; Wendy Strugnell; Adrian G Barnett; Andrew J Clarke; Judith Bellapart; Michael P Vallely; Peter J Tesar; John F Fraser
Journal:  BMC Cardiovasc Disord       Date:  2014-04-05       Impact factor: 2.298

Review 10.  The epidemiology of silent brain infarction: a systematic review of population-based cohorts.

Authors:  Jonathon P Fanning; Andrew A Wong; John F Fraser
Journal:  BMC Med       Date:  2014-07-09       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.